Nancy Liu

3.9k total citations
73 papers, 3.1k citations indexed

About

Nancy Liu is a scholar working on Molecular Biology, Infectious Diseases and Physiology. According to data from OpenAlex, Nancy Liu has authored 73 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Infectious Diseases and 9 papers in Physiology. Recurrent topics in Nancy Liu's work include HIV/AIDS Research and Interventions (8 papers), Asthma and respiratory diseases (8 papers) and Allergic Rhinitis and Sensitization (5 papers). Nancy Liu is often cited by papers focused on HIV/AIDS Research and Interventions (8 papers), Asthma and respiratory diseases (8 papers) and Allergic Rhinitis and Sensitization (5 papers). Nancy Liu collaborates with scholars based in United States, Canada and China. Nancy Liu's co-authors include Bill G. Kapogiannis, Madhav V. Dhodapkar, Hani Hassoun, Craig M. Wilson, D. Chang, Zarina Iqbal, William H. Slattery, Laurel M. Fisher, Jay R. Lieberman and Bret J. Rudy and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Clinical Infectious Diseases.

In The Last Decade

Nancy Liu

68 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Liu United States 27 564 548 538 517 445 73 3.1k
Martina Fabris Italy 37 646 1.1× 768 1.4× 451 0.8× 777 1.5× 359 0.8× 146 4.5k
Inés Colmegna Canada 27 194 0.3× 617 1.1× 332 0.6× 707 1.4× 252 0.6× 97 2.3k
Scott M. Whitcup United States 55 241 0.4× 948 1.7× 1.1k 2.0× 1.0k 2.0× 414 0.9× 195 11.9k
Qing Zhang China 27 244 0.4× 658 1.2× 591 1.1× 942 1.8× 474 1.1× 187 3.1k
Virgil A. S. H. Dalm Netherlands 31 299 0.5× 561 1.0× 468 0.9× 978 1.9× 321 0.7× 128 2.9k
Sébastien Viel France 24 447 0.8× 523 1.0× 285 0.5× 1.9k 3.7× 509 1.1× 64 3.6k
Rosanna Vescovini Italy 23 149 0.3× 465 0.8× 635 1.2× 1.3k 2.5× 464 1.0× 46 2.6k
Henry J. Kaminski United States 43 1.4k 2.4× 1.4k 2.5× 342 0.6× 512 1.0× 336 0.8× 206 7.8k
Makoto Yoshida Japan 29 171 0.3× 564 1.0× 199 0.4× 334 0.6× 365 0.8× 212 3.2k
Brian P. O’Connor United States 35 168 0.3× 1.1k 2.0× 299 0.6× 2.3k 4.4× 507 1.1× 85 3.9k

Countries citing papers authored by Nancy Liu

Since Specialization
Citations

This map shows the geographic impact of Nancy Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Liu more than expected).

Fields of papers citing papers by Nancy Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Liu. The network helps show where Nancy Liu may publish in the future.

Co-authorship network of co-authors of Nancy Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Liu. A scholar is included among the top collaborators of Nancy Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Liu. Nancy Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benedetti, Fabrizio De, Ivan Foeldvari, Nadina Rubio‐Pérez, et al.. (2025). Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and 1‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study. Arthritis Care & Research.
2.
Liu, Nancy, Jorge R. Georgakopoulos, Khalad Maliyar, et al.. (2024). Development of Vitiligo in Patients Treated With BRAF/MEK Inhibitors: A Systematic Review. Journal of Cutaneous Medicine and Surgery. 28(2). 200–201.
3.
Seo, Eun Hyun, et al.. (2024). Anxiety Symptoms and Associated Psychological and Job-Related Factors Among Hospital Nurses. Psychiatry Investigation. 21(1). 100–108. 3 indexed citations
4.
Liu, Nancy & Roswita Dressler. (2024). The contribution of exterior schoolscapes to neighbourhoods: a linguistic landscape analysis during COVID-19 school closures. International Journal of Multilingualism. 22(3). 1378–1397. 1 indexed citations
5.
6.
Aguilera, Adrián, et al.. (2017). Implementing Group CBT for Depression Among Latinos in a Primary Care Clinic. Cognitive and Behavioral Practice. 25(1). 135–144. 22 indexed citations
7.
Abu‐Laban, Riyad B., et al.. (2015). Effect of Triage Nurse Initiated Radiography Using the Ottawa Ankle Rules on Emergency Department Length of Stay at a Tertiary Centre. Canadian Journal of Emergency Medicine. 18(2). 90–97. 21 indexed citations
8.
Yao, Qingqiang, Bo Wei, Nancy Liu, et al.. (2014). Chondrogenic Regeneration Using Bone Marrow Clots and a Porous Polycaprolactone-Hydroxyapatite Scaffold by Three-Dimensional Printing. Tissue Engineering Part A. 21(7-8). 1388–1397. 39 indexed citations
9.
Nolte, Hendrik, Jacques Hébert, Gary Berman, et al.. (2013). Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Annals of Allergy Asthma & Immunology. 110(6). 450–456.e4. 84 indexed citations
10.
Greenberg, Steven, Nancy Liu, Amarjot Kaur, et al.. (2012). Airway obstruction lability helps distinguish levels of disease activity in asthma. Respiratory Medicine. 106(4). 500–507. 5 indexed citations
11.
Kasckow, John, Nancy Liu, Gretchen L. Haas, & Michael R. Phillips. (2010). Case-control study of the relationship of depressive symptoms to suicide in a community-based sample of individuals with schizophrenia in China. Schizophrenia Research. 122(1-3). 226–231. 18 indexed citations
12.
Bernstein, Jonathan A., Nancy Liu, Barbara Knorr, et al.. (2010). MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease. Respiratory Medicine. 105(3). 392–401. 26 indexed citations
13.
Lu, Susan, Nancy Liu, Sairia Dass, Theodore F. Reiss, & Barbara Knorr. (2009). Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma. Respiratory Medicine. 103(3). 342–347. 14 indexed citations
14.
Philip, George, Janet van Adelsberg, Tom Loeys, et al.. (2009). Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis. Journal of Allergy and Clinical Immunology. 124(5). 942–948.e9. 47 indexed citations
15.
16.
Parving, Hans‐Henrik, Dick de Zeeuw, Mark E. Cooper, et al.. (2008). ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy. Journal of the American Society of Nephrology. 19(4). 771–779. 70 indexed citations
17.
Viani, Rolando M., Lígia Peralta, Grace M. Aldrovandi, et al.. (2006). Prevalence of Primary HIV‐1 Drug Resistance among Recently Infected Adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study. The Journal of Infectious Diseases. 194(11). 1505–1509. 45 indexed citations
18.
Liu, Cun‐Zhi, et al.. (2005). Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK. Experimental Cell Research. 309(2). 410–418. 53 indexed citations
19.
Feeley, Brian T., Lucie Krenek, Nancy Liu, et al.. (2005). Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions. Bone. 38(2). 154–166. 124 indexed citations
20.
Apter, David E., et al.. (1994). Wang Shiwei and "Wild lilies" : rectification and purges in the Chinese Communist Party, 1942-1944. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Fabris Breakdown of academic impact, for papers by Inés Colmegna Breakdown of academic impact, for papers by Scott M. Whitcup Breakdown of academic impact, for papers by Qing Zhang Breakdown of academic impact, for papers by Virgil A. S. H. Dalm Breakdown of academic impact, for papers by Sébastien Viel Breakdown of academic impact, for papers by Rosanna Vescovini Breakdown of academic impact, for papers by Henry J. Kaminski Breakdown of academic impact, for papers by Makoto Yoshida Breakdown of academic impact, for papers by Brian P. O’Connor
Rankless by CCL
2026